$MXCT Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.08 up 33.33% YoY
• Reported revenue of $7.27M down -14.53% YoY
• MaxCyte expects full year 2026 revenue of $30 million to $32 million, consisting of $25 million to $27 million in core revenue and approximately $5 million in SPL Program-related revenue.